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Abstract
Background: Preeclampsia is one of the leading causes of maternal and perinatal mortality and morbidity worldwide
and its pathogenesis is not totally understood. As a member of the chromosomal passenger complex and an inhibitor
of apoptosis, survivin is a well-characterized oncoprotein. Its roles in trophoblastic cells remain to be defined.
Methods: The placental samples from 16 preeclampsia patients and 16 well-matched controls were included in this
study. Real-time PCR, immunohistochemistry and Western blot analysis were carried out with placental tissues.
Primary trophoblastic cells from term placentas were isolated for Western blot analysis. Cell proliferation, cell cycle
analysis and immunofluorescence staining were performed in trophoblastic cell lines BeWo, JAR and HTR-8/SVneo.
Results:  The  survivin  gene  is  reduced  but  the  protein  amount  is  hardly  changed  in  preeclamptic  placentas,
compared to control placentas. Upon stress, survivin in trophoblastic cells is phosphorylated on its residue serine 20
by protein kinase A and becomes stabilized, accompanied by increased heat shock protein 90. Depletion of survivin
induces chromosome misalignment, abnormal centrosome integrity, and reduced localization and activity of Aurora B
at the centromeres/kinetochores in trophoblastic metaphase cells.
Conclusions: Our data indicate that survivin plays pivotal roles in cell survival and proliferation of trophoblastic cells.
Further investigations are required to define the function of survivin in each cell type of the placenta in the context of
proliferation, differentiation, apoptosis, angiogenesis, migration and invasion.
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Introduction
Survivin, a well-characterized oncoprotein, is best known for
its participation in the chromosomal passenger complex (CPC),
its  capability  to  inhibit  apoptosis  and  its  involvement  in  the
cellular stress response [1,2]. The gene expression of survivin
is controlled by many cell signaling pathways at transcriptional
and post-transcriptional levels [1,3,4]. While several oncogenic
factors  stimulate  expression  of  the  survivin  gene,  tumor
suppressors  repress  it  [5].  Survivin  is  located  in  the  cytosol,
mitochondria  and  nucleus  [6,7],  which  is  tightly  linked  to  its
various cellular functions. While the nuclear pool mediates its
mitotic  role,  the  cytosolic  and  mitochondrial  fractions  are
responsible for its anti-apoptotic capability [7,8]. In response to
apoptotic stimuli, survivin is trafficked from the mitochondria to
the cytosol where it can inhibit apoptosis [7].
Survivin acts as an important regulatory member of the CPC
in mitosis [9]. It is involved in proper chromosome alignment,
spindle  assembly,  spindle  stability  via  the  suppression  of
microtubule  dynamics  [10]  and  kinetochore-microtubule
attachment [11]. In mitosis, survivin is precisely regulated by
Aurora  B,  Polo-like  kinase  1  (Plk1)  and  cyclin-dependent
kinase 1 (Cdk1) by phosphorylating its residues T117, S20 and
T34,  respectively  [12–15].  Interfering  with  these  regulations
results  in  misaligned  chromosomes,  malattachment  of  the
microtubule-kinetochore  and  defective  cytokinesis  [13–15].  In
addition, survivin is highly expressed in various cancers and is
linked to malignant progression, metastasis, therapy resistance
and poor prognosis of patients [2].
Interestingly, survivin has been reported to be overexpressed
in  hydatidiform  mole  and  choriocarcinoma  [16,17].  Survivin
promotes  trophoblast  survival  by  showing  decreased  cell
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treated  with  antisense  oligonucleotides  [18].  While  a  higher
level  of  survivin  at  the  murine  feto-maternal  interface  was
suggested  to  be  involved  in  pregnancy  loss,  upregulated
survivin was proposed to support trophoblast survival and thus
maintain pregnancy during placentation [19].
The  expression  level  of  survivin  in  preeclamptic  placentas
has also been controversially reported [20,21]. Preeclampsia,
characterized by the new onset of hypertension and proteinuria
after 20 weeks of gestation, is a complex disorder manifested
by impaired implantation, endothelial dysfunction and systemic
inflammation [22,23]. It affects 2–8% of all pregnancies and is
one of the leading causes of maternal and perinatal mortality
and  morbidity  worldwide  [24].  Despite  intensive  research,  its
pathogenesis is not totally understood [22–25]. In our previous
work,  based  on  our  own  designed  gene  arrays  (manuscript
submitted), we observed that the gene coding for survivin was
reduced in preeclamptic placenta compared to control. The aim
of this study is to verify the data using quantitative real-time
PCR  and  immunohistochemistry  in  bigger  collectives,  and  to
study the molecular function of survivin in trophoblastic cells of
the placenta.
Materials and Methods
Sample collection
This  study  was  approved  by  the  Ethics  Committees  at
Frankfurt  University  Hospital.  Written  informed  consent  was
obtained  from  preeclampsia  patients  and  controls.
Preeclampsia  was  diagnosed  as  described  [26].  Placenta
samples (0.5 cm3) were taken from the four quadrants of the
fetal side of placentas within 30 minutes post-delivery, frozen
immediately in liquid nitrogen and stored at -80°C until use.
RNA extraction, real-time PCR and data analysis
Total  RNAs  were  extracted  with  RNeasy  kits  with  column
DNase  digestion  according  to  the  manual  instructions
(QIAGEN, Hilden). Reverse transcription was performed using
High-Capacity  cDNA  Reverse  Transcription  Kit  as  instructed
(Applied Biosystems, Darmstadt). The primers and probes for
survivin and Aurora B were obtained from Applied Biosystems.
Real-time PCR was performed with a StepOnePlus Real-time
PCR  System  (Applied  Biosystems).  The  data  were  analyzed
using  StepOne  Software  v2.2.2  (Applied  Biosystems).  Using
the  comparative  CT  method  [27],  the  gene  expression  was
represented  as  ΔCt,  which  is  normalized  to  endogenous
controls  and  is  reversely  related  to  the  amount  of  target
molecules in the reaction. The mean value of expression levels
of  three  genes  SDHA  (succinate  dehydrogenase  complex,
subunit A), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide) and TBP
(TATA  box-binding  protein)  served  as  endogenous  controls
[28].  The  final  results  were  represented  as  relative
quantification (RQ), the difference in survivin expression level
between preeclampsia samples and normal placenta samples,
by setting the expression values of the normal placenta as 1, in
medians  with  minimum  and  maximum  range.  The  RQ  of  a
group is defined as 2-(ΔCTgroup-ΔCTcontrol), therefore, the RQ value
for  the  control  group  itself  leads  to  the  value  RQ=1  without
variation. In the bar chart the RQ value of the control group is
omitted and served just as a benchmark.
Immunohistochemistry and Western blot analysis of
placenta tissues
Formalin-fixed,  paraffin-embedded  placenta  tissue  sections
were deparaffinized and further treated with 4% (v/v) hydrogen
peroxide in TRIS-buffered saline (TBS) for 15 minutes. Antigen
retrieval  was  carried  out  by  exposure  to  pressure  cooker
conditions for 20 minutes with 10 mM citrate buffer, pH 6.0.
Nonspecific  binding  was  blocked  with  blocking  buffer  (Santa
Cruz  Biotechnology,  Heidelberg)  for  1  hour  at  room
temperature.  Sections  were  then  incubated  with  rabbit
monoclonal  anti-survivin  antibody  (1:150,  Cell  Signaling,
Beverley) overnight at 4°C and additional 30 minutes at room
temperature.  Non-immune  rabbit  IgG  (Santa  Cruz
Biotechnology)  was  taken  as  negative  control.  After  washing
with TBS, sections were incubated with biotinylated goat anti-
rabbit antibodies (Santa Cruz Biotechnology) for 40 minutes at
room  temperature,  followed  by  washing  with  TBS.  After
incubation in a streptavidin-peroxidase conjugate, the antibody
complexes  were  visualized  through  exposure  to  3-amino-9-
ethylcarbazole  (AEC)  substrate  (DAKO,  Hamburg)  for  3
minutes.  Sections  were  counterstained  with  hematoxylin,
mounted and examined using an Axio Imager 7.1 microscope
(Zeiss,  Göttingen).  Semi-quantitative  analysis  (HScore)  of
survivin staining was performed based on the combination of
staining  intensity  with  the  percentage  of  positive  cells  [21].
Briefly, no staining was scored as 0, 1–10% of positive cells
stained  scored  as  1,  10–50%  as  2,  50–80%  as  3,  and  80–
100% as 4. Staining intensity was rated on a scale of 0–3, with
0=negative, 1=weak, 2=moderate and 3=strong. The raw data
were  converted  by  multiplying  the  quantity  and  staining
intensity  scores.  Negative  controls  were  stained  with  non-
immune antibody.
Cellular lysates from placental tissues were performed using
total  protein  extraction  kits  from  Millipore  (Schwalbach),  as
instructed.  For  the  extraction  of  cytoplasmic  and  nuclear
proteins  from  placental  tissues,  a  compartmental  protein
extraction kit was used (Millipore). Western blot analyses with
tissue extracts were carried out as described [29,30]. Primary
polyclonal  rabbit  antibody  against  survivin  was  from  R&D
systems (1:750, Minneapolis).
Primary trophoblast isolation
Primary trophoblasts were isolated from term placentas as
described [31]. Briefly, 50 g placenta tissue was finely minced,
rinsed and digested with trypsin (Life Technology, Darmstadt)
and DNase I (Sigma-Aldrich, Taufkirchen) for 20 min at 37°C
on a shaker. The digestion was repeated two more times. The
suspension was centrifuged at 1000 g for 10 min, resuspended
and  filtered  with  a  100  µm  nylon  cell  strainer.  The  filtered
suspension  was  again  centrifuged  before  laying  on  two
performed percoll density gradients ranging from 70% to 5%.
The gradients were centrifuged and the cells ranging between
the density 1.048 and 1.064 were collected. After centrifugation
and counting, cells were seeded at a density of 2 x 105 cells
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Technology). The purity of isolated primary trophoblasts from
term  placentas  was  analyzed  by  using  both  indirect
immunofluorescence  staining  and  immunocytochemistry  with
antibodies  against  vimentin  (1:100,  absent,  for  non-
trophoblasts),  cytokeratin-7  (1:100,  positive  for  both
cytotrophoblasts and syncytiotrophoblasts) and cytokeratin-18
(1:50, positive for cytotrophoblasts). Cells were then stimulated
and harvested for Western blot analysis.
Cell culture, cell cycle analysis, Western blot analysis
and immunofluorescence staining
BeWo,  JAR  and  HTR-8/SVneo  (HTR)  [32]  cells  were
cultured  as  instructed.  H2O2  and  YM155  were  obtained  from
Merck (Darmstadt) and forskolin from Sigma-Aldrich. Cell cycle
profile  was  analyzed  using  a  FACSCalibur  (BD  Biosciences,
Heidelberg),  as  described  [33].  Briefly,  cells  were  harvested,
washed with PBS, fixed in chilled 70% ethanol at 4°C for at
least 30 min, treated with 1 mg/ml of RNase A (Sigma-Aldrich)
and stained with 100 µg/ml of propidium iodide for 30 min at
37°C. DNA content was determined by FACS. The data were
analyzed with CellQuest software (BD Biosciences).
Cell lysis was performed using RIPA buffer (50 mM Tris-HCl
pH  8.0,  150  mM  NaCl,  1%  NP-40,  0.5%  Na-desoxycholate,
0.1% SDS, 1 mM NaF, 1 mM DTT, 0.4 mM PMSF, 0.1 mM Na
3VO4,  and  protease  inhibitor  cocktail  complete  (Roche,
Mannheim)).  Western  blot  analysis  was  performed,  as
previously described [34]. The following antibodies were used
for  Western  blot  analysis:  mouse  monoclonal  antibodies
against  Plk1,  p53  and  Bax  (1:1000,  1:500  and  1:500,
respectively,  Santa  Cruz  Biotechnology),  rabbit  polyclonal
antibody  against  phospho-p53  (S15)  (1:500,  Cell  Signaling),
rabbit  polyclonal  antibody  against  survivin  (1:750,  R&D
Systems), rabbit polyclonal antibodies against p21 and against
poly(ADP-ribose)  polymerase  (PARP)  (both  1:1000,  Cell
Signaling), rabbit polyclonal antibody against phospho-survivin
(S20)  (1:1000,  Novus  Biologicals,  Cambridge),  mouse
monoclonal  antibody  against  heat  shock  protein  90  (Hsp90)
(1:1000, Abcam, Berlin), mouse monoclonal antibody against
Bcl-2  (1:500,  Millipore)  and  mouse  monoclonal  antibodies
against  β-actin  (1:200,000,  Sigma-Aldrich,  Taufkirchen)  and
lamin B1 (1:1000, MDL, Woburn).
Indirect  immunofluorescence  staining  was  performed  as
described [29,30,34]. In brief, control or treated cells were fixed
for 15 min with 4% PFA containing 0.1% Triton ®X-100 at room
temperature.  The  following  primary  antibodies  were  used  for
staining: polyclonal rabbit antibody against pericentrin (1:800,
Abcam),  immune  serum  against  centromere  (1:400,  anti-
centromere  antibody,  ACA,  ImmunoVision),  polyclonal  rabbit
antibody  against  survivin  (1:1000,  R&D  Systems),  polyclonal
rabbit  antibody  against  Aurora  B  (1:150,  Cell  Signaling),
monoclonal  mouse  antibodies  against  vimentin  and
cytokeratin-7 (both 1:100, DAKO), monoclonal rabbit antibody
against  cytokeratin-18  (1:50,  Abcam)  and  FITC-conjugated
mouse monoclonal antibody against α-tubulin (1:500, Sigma-
Aldrich).  DNA  was  stained  using  DAPI  (4’,6-diamidino-2-
phenylindole-dihydrochlorid)  (Roche).  Slides  were  examined
using an Axio Imager 7.1 microscope (Zeiss) and images were
taken  using  an  Axio  Cam  MRm  camera  (Zeiss).  The
immunofluorescence stained slides were also examined by a
confocal laser scanning microscope (CLSM) (Leica CTR 6500,
Heidelberg). Images were processed using Photoshop.
siRNA transfection, active caspase-3/7 measurement
and cell proliferation assay
siRNA  targeting  survivin  (sense:
GCAGGUUCCUUAUCUGUCA  and  antisense
UGACAGAUAAGGAACCUGC)  was  manufactured  by  Sigma-
Aldrich. Control siRNA was obtained from Qiagen. siRNA (20
nM, unless otherwise stated) was transiently transfected using
transfection  reagent  OligofectamineTM  as  instructed  (Life
Technology).  The  activity  of  caspase-3/7  was  analyzed  with
Caspase-Glo®  3/7  Assay  (Promega  GmbH,  Mannheim).  Cell
proliferation assays were carried out by using Cell Titer-Blue®
Cell Viability Assay on treated cells in 96-well plates, based on
the reduction of the indicator dye Resazurin into Resorufin by
viable cells (Promega GmbH). 20 µl of CellTiter-Blue® reagent
was added to each well and then incubated at 37°C with 5%
CO2 for 3 h before fluorescence reading using a Victor 1420
Multilabel  Counter  (Wallac).  Experiments  were  performed  in
triplicate.  Data  were  presented  as  percentages  compared  to
control.
Statistical analysis
The  student’s  t-test  (two  tailed  and  paired)  was  used  to
evaluate the significance of difference between two groups with
normal  distribution.  Otherwise  the  non-parametric  Mann-
Whitney  U-Test  was  used  between  the  patient  group  and
control  group.  Difference  was  considered  as  statistically
significant when p< 0.05.
Results
To select matched normal controls for preeclampsia patients,
special attention was paid to gestational age, delivery mode,
body mass index (BMI) and maternal age. The clinical data of
16  preeclampsia  patients  and  16  well-matched  controls  are
summarized in Table 1. There was no significant difference in
gestational  age,  maternal  age  and  BMI  between  normal
pregnancies and those complicated by preeclampsia.
The mRNA level of survivin was decreased in
preeclamptic placentas
According to the instruction of the comparative CT analysis
protocol  [27],  the  expression  values  of  the  normal  control
placentas  was  set  as  1.  The  mRNA  level  of  survivin  in
preeclamptic  placentas  was  significantly  decreased,  only
45.2%  of  that  in  normal  placentas  (Figure  1A),  which  is
consistent with our previous data (manuscript submitted). The
relative mRNA levels of survivin of both groups are illustrated in
Figure 1B.
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preeclamptic placentas
Unexpectedly, the protein levels of survivin between the two
groups  were  not  obviously  different  (Figure  2A).  Further
quantification of the survivin bands in Western blots showed no
significant  alteration  in  the  protein  level  between  the
preeclampsia  group  and  the  control  group  (Figure  2B).  By
immunohistochemical staining, survivin was to be clearly found
in villous cytotrophoblasts and syncytiotrophoblasts (Figure 2C,
a-d). The signal was not observed in placenta tissue stained
with  either  control  IgG  (Figure  2C,  e)  or  survivin  antibody
neutralized with corresponding peptide (Figure 2C, f), indicating
that the staining signal of survivin is specific. Interestingly, the
survivin signal was predominant in the nucleus but also to be
Figure  1.    Survivin  gene  is  reduced  in  preeclamptic
placentas.    (A)  Relative  amount  of  the  gene  survivin  in
preeclamptic placentas (PE, n=16), in comparison with control
placentas (n=16). The results are presented by mean of RQ
with minimum and maximum range and statistically analyzed
between  control  and  PE  group.  *p  <  0.05.  RQ:  relative
quantification  of  fold  by  setting  the  control  value  as  1,  as
described in the Materials and Methods section. The RQ value
of the control group is omitted and served just as a benchmark.
(B)  Individual  expression  levels  of  the  survivin  gene  in  both
preeclampsia and control groups, represented by ΔCt values,
which  are  normalized  to  endogenous  controls  and  are
reversely  related  to  the  amount  of  target  molecules,  as
described in the Materials and Methods section. Bar: median
value.
doi: 10.1371/journal.pone.0073337.g001
found in the cytoplasm (Figure 2C, a-d). Of note, the survivin
staining was easily detectable in the nuclei of syncytial sprout
cells (Figure 2D, a). In addition, the staining signal was also
observable  in  syncytial  knot  cells  (Figure  2D,  b)  in  both
preeclamptic placentas as well as in normal placentas. Further
evaluation in each subtype of placental cells showed that the
percentages  of  positive  staining  of  survivin  in  villous
cytotrophoblasts  and  syncytiotrophoblasts  were  even  slightly,
although not significantly, higher in preeclamptic placentas than
in matched control placentas (Figure 2E). Finally, according to
HScore  evaluation,  described  in  the  Materials  and  Methods
section, there was no difference of survivin staining in villous
cytotrophoblasts  and  syncytiotrophoblasts  between
preeclampsia placentas and control placentas (Figure 2F). To
corroborate  the  predominant  nuclear  localization  of  survivin
observed  in  immunohistochemical  staining,  we  separated
cytosol and nuclear extracts of placenta tissues and performed
Western blot analysis using another specific antibody against
survivin,  not  the  antibody  used  in  immunohistochemistry.  As
shown  in  Figure  2G,  it  was  obvious  that  the  major  pool  of
survivin was found in nuclear extracts of placental tissues.
Survivin was stabilized and its residue serine 20 is
phosphorylated upon stress
We were wondering why the discrepancy exists between the
gene expression and protein level of survivin in preeclamptic
placentas.  It  is  well  known  that  transcript  abundances  only
partially  predict  protein  abundances  because  of  substantial
regulatory  processes  occurring  after  mRNA  is  translated
[35–37].  Preeclamptic  placenta  is  characterized  by  ischemia
and  hypoxia  and  it  releases  variety  of  stress  mediators
including  reactive  oxygen  species  (ROS),  such  as  hydrogen
peroxide  (H2O2)  [38].  Trophoblastic  cells  in  the  preeclamptic
placentas  encounter  therefore  perpetually  enormous  cellular
stress  and  we  asked  whether  the  stress  could  modify  the
protein survivin and affect its turnover. To clarify this issue, we
analyzed  the  protein  stability  of  survivin  upon  stress  in
trophoblastic cells. JAR cells, trophoblastic cells derived from
choriocarcinoma, were stimulated with H2O2 for indicated time
periods  and  cellular  lysates  were  prepared  for  Western  blot
analysis. As displayed in Figure 3A, H 2O2 apparently stabilized
survivin at 4 h and reached its peak at 6 h (Figure 3A, 5th row),
accompanied by increased p53 (Figure 3A, 2nd row), phospho-
p53 (Figure 3A, 3rd row) and p21 (Figure 3A, 4th row), the stress
indicators. In particular, the residue serine 20 (S20) in survivin
was phosphorylated (Figure 3A, 6th row) and heat shock protein
90 (Hsp90) was elevated upon H2O2 treatment (Figure 3A, 1st
row). The mRNA levels of survivin and Aurora B at 6 h were
Table 1. Clinical information of 16 preeclampsia patients and 16 controls.
  age gestational age (weeks) body mass index birth weight (g) systolic BP (mmHg) diastolic BP (mmHg) proteinuria (mg/24h)
control 33.6±6.4 37.0±4.2 26.6±3.8 3022±899 126±16 74±13 0
preeclampsia 31.6±4.2 36.8±3.9 26.4±4.9 2650±742 167±27 101±14 1792±2185
P value 0.28 0.93 0.86 0.16 0.00001 0.00001 -
doi: 10.1371/journal.pone.0073337.t001
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Western blot analysis of control placentas (con, n=16) and preeclamptic placentas (PE, n=16). The representatives are shown. (B)
Quantification of the relative amounts of survivin protein in the control group and in the preeclampsia group from Western blot
analysis.  Bar:  standard  deviation  (±  SD).  (C)  The  representatives  of  immunohistochemical  staining  with  survivin  antibody  in
preeclampsia placentas (a and b) and in control placentas (c and d). Open arrowheads and closed arrowheads indicate some of
stained  syncytiotrophoblasts  and  cytotrophoblasts,  respectively.  Immunohistochemical  stainings  with  control  IgG  or  survivin
antibody neutralized with corresponding peptide are presented as controls (e and f). Scale bar: 10 µm. (D) Clear signals of survivin
in syncytial sprout cells (black arrows in a, magnification of Figure 2C, a) and signals in syncytial knots (black arrows in b). Scale
bar: 10 µm. (E) Quantification of positive cells of survivin staining in 7 placenta samples from PE patients and 7 samples from
matched controls (n=1500 cells per cell type). CT: villous cytotrophoblasts. ST: syncytiotrophoblasts. Sprouts/knots: syncytial sprout
cells and syncytial knots. Bar: ± SD. (F) Quantification of survivin positive rate using HScore method, as described in the Materials
and  Methods  section,  in  villous  cytotrophoblasts  (CT)  and  syncytiotrophoblasts  (ST).  Bar:  ±  SD.  con:  control  placenta.  PE:
preeclamptic placenta. (G) Western blot analysis using cytosol (C) or nuclear extracts (N) from placentas. Lamin B1 served as
nuclear extract marker.
doi: 10.1371/journal.pone.0073337.g002
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localization of stabilized survivin, the treated cells were fixed
and stained for tubulin, survivin and DNA. The localization of
survivin was not altered but intensity of the signal was slightly
increased after H2O2 treatment (Figure 3C).
It  has  been  reported  that  the  residue  S20  in  survivin  is
phosphorylated by both protein kinase A (PKA) [39] and Polo-
like kinase 1 (Plk1) [14]. As Plk1 is mainly active in mitosis, we
assumed  that  phosphorylation  of  S20  in  survivin  could  be
ascribed to an activation of PKA in trophoblastic cells subjected
to H2O2. To test this, BeWo cells, another trophoblastic cell line
derived  from  choriocarcinoma,  were  treated  with  20  µM
forskolin, an activator of PKA. Treated cells were harvested at
indicated  time  points  for  Western  blot  analysis.  The  residue
S20  of  survivin  was  indeed  phosphorylated  after  forskolin
treatment  (Figure  3D,  6th  row),  associated  with  stabilized
survivin (Figure 3D, 5th row) and elevated Hsp90 (Figure 3D, 1st
row).  In  addition,  the  stress  indicators  were  also  increased,
including p53, p-p53 and p21 (Figure 3D, 2nd to 4th rows). The
same experiment was also carried out in HTR-8/SVneo cells,
immortalized  normal  1st  term  trophoblast  cells,  and  similar
results were observed (data not shown).
To  investigate  the  survival  role  of  survivin  in  trophoblastic
cells, JAR cells were treated with siRNA targeting survivin (2.5,
7.5 and 10 nM) for 18 h. Cells were then challenged by the
stress  inducer  H2O2  for  12  h  and  cellular  extracts  were
prepared  for  Western  blot  analysis.  Survivin  was  efficiently
depleted  in  JAR  cells  in  a  siRNA  dose  dependent  manner
(Figure 3E, 4th row, lanes 3, 5 and 7). Again, H2O2 treatment
stabilized the survivin protein (Figure 3E, 4th row, lanes 2 and
10,  5th  row,  lanes  4  and  8).  Along  with  reduced  survivin,
cleaved  poly(ADP-ribose)  polymerase  (PARP),  an  apoptosis
marker, was enhanced (Figure 3E, 1st row, lanes 4, 6 and 8)
with increased pro-apoptotic protein Bax (Figure 3E, 2nd row,
lanes 4, 6 and 8). Intriguingly, the anti-apoptotic protein Bcl-2
was  also  enhanced  (Figure  3E,  3rd  row,  lanes  4,  6  and  8),
which was not able to block the apoptotic response induced by
H2O2.  In  consistence  with  these  results,  the  caspase-3/7
activity in JAR cells treated with H2O2 was elevated, dependent
inversely on remaining survivin amounts (Figure 3F).
Moreover,  to  corroborate  these  data,  primary  trophoblastic
cells were isolated from term placentas. The characterization
was  carried  out  by  staining  the  isolated  primary  cells  with
antibodies  against  vimentin,  cytokeratin-7  and  cytokeratin-18
(Figure S1). Primary trophoblasts were stimulated with H2O2 (5,
10, 20, 30 and 50 µM) for 6 h or with forskolin (10, 20, 30, 40
and  50  µM)  for  8  h  and  cellular  lysates  were  prepared  for
Western  blot  analysis.  In  accordance  with  the  results  from
trophoblastic cell lines, survivin was clearly stabilized with H2O2
treatment (Figure 3G) and with forskolin (Figure 3H) in primary
trophoblast cells, accompanied by increased levels of Hsp90
and  p53.  Collectively,  the  data  indicate  that,  upon  stress,
survivin in trophoblastic cells is stabilized, which is associated
with increased Hsp90 and activated PKA.
Depletion of survivin inhibits proliferation of
trophoblastic cells by arresting them in G2/M and by
inducing apoptosis
As  a  member  of  the  CPC,  survivin  promotes  mitosis  and
therefore  proliferation.  To  address  the  proliferative  role  of
survivin  in  trophoblasts  of  the  placenta,  JAR,  BeWo  and
HTR-8/SVneo were treated with siRNA targeting survivin and
cell viability was then monitored. Regardless of whether normal
or malignant, depletion of survivin disrupted proliferation of all
three  trophoblastic  cell  lines  (Figure  4A),  suggesting  the
importance  of  survivin  for  trophoblast  division.  Cell  cycle
analysis showed that trophoblast cells were arrested in G2/M
upon deletion of survivin (Figure 4B). To explore if apoptosis
took  place  after  G2/M  arrest,  BeWo  cells  were  treated  with
siRNA against survivin and cellular extracts were prepared for
Western blot analysis. Cleaved PARP was increased in BeWo
cells after treatment with siRNA against survivin (Figure 4C, 1st
row).  In  line  with  these  results,  the  caspase-3/7  activity  was
strongly enhanced in BeWo and JAR cells treated with siRNA
targeting survivin, particularly at 48 h (Figure 4D).
To  verify  the  data,  trophoblastic  cells  were  incubated  with
YM155, a specific small molecule suppressant of the survivin
expression  [40].  The  survivin  level  in  treated  JAR  cells  was
convincingly  reduced  (Figure  5A),  along  with  an  increased
peak of G2/M arrest (Figure 5B and C), a strongly enhanced
induction  of  apoptosis  (Figure  5A  and  D)  and  inhibited  cell
proliferation  (Figure  5E).  The  same  experiments  were  also
carried  out  with  BeWo  cells  and  the  similar  results  were
obtained (Figure S2).
Suppression of survivin resulted in misaligned
chromosomes and abnormal centrosomes
As  an  important  regulatory  member  of  the  CPC,  survivin
plays multiple roles throughout mitosis. We were interested in
the mitotic phenotype of trophoblastic cells in the absence of
survivin. BeWo and JAR cells, depleted of survivin, were fixed
and stained for microtubule marker tubulin, centrosome marker
pericentrin  and  DNA.  Metaphase  cells  were  examined  by
confocal laser scanning microscopy. Compared to control cells
(Figure  6A,  1st  and  2nd  panels),  BeWo  cells  without  survivin
showed defects in chromosome congression (Figure 6A, 3rd to
6th panels, DAPI staining). Moreover, centrosome abnormality,
more than two centrosomes yet often clustering into two poles,
was  observed  (Figure  6A,  5th  and  6th  panels,  pericentrin
staining), often associated with abnormal spindle form (Figure
6A, 5th panel, tubulin staining). Further evaluation showed that
74.7% of BeWo cells displayed misaligned chromosomes in the
absence of survivin, compared to about 20% in control cells
(Figure 6B). In addition, while 11.7% of control cells showed
abnormal  centrosomes,  31.6%  of  BeWo  cells  exhibited  this
defect  after  treatment  with  siRNA  targeting  survivin  (Figure
6C). The same experiment was also performed in JAR cells
and similar results were observed (Figure 6D and E).
Reduced localization and activity of Aurora B in
trophoblastic metaphase cells
As survivin is responsible for the localization of Aurora B at
the  centromere  of  the  chromosome  by  binding  directly  to
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PLOS ONE | www.plosone.org 6 September 2013 | Volume 8 | Issue 9 | e73337Figure 3.  Survivin is stabilized and protects trophoblastic cells from apoptosis upon stress.  (A) Western blot analysis. JAR
cells were treated with 10 µM H2O2 and cellular lysates were prepared at 0, 4, 6, 8 and 10 h for Western blot analysis using
antibodies as indicated. β-actin served as loading control. (B) Gene levels of survivin and Aurora B. Cells were treated as in (A) for
6 h and total RNA was isolated for real-time PCR analysis. The results are based on three independent experiments and presented
as mean ± SEM. The RQ value of the untreated control cells is omitted and served just as a benchmark. (C) Immunofluorescence
staining. JAR cells were treated with H2O2 for 6 h, fixed and stained for tubulin, survivin and DNA. Scale bar: 5 µm. (D) BeWo cells
were treated with 20 µM forskolin for 0, 2, 4, 6, 8 and 10 h and cellular extracts were prepared for Western blot analysis with
indicated antibodies. β-actin served as loading control. (E) Western blot analysis. JAR cells were non-treated (con), treated with
scrambled siRNA (si con) or with siRNA targeting survivin (2.5, 7.5 and 10 nM) for 18 h and were then challenged with 10 µM H2O2
for additional 12 h. Cellular lysates were prepared for Western blot analysis with indicated antibodies. β-actin served as loading
control. (F) Relative activity of caspase-3/7. The lysates from JAR cells treated as in (F) were used for evaluating caspase-3/7
activity. The results are presented as mean ± SD. (G) Western blot analysis. Primary trophoblasts were isolated from term placentas
and stimulated with indicated concentrations of H2O2 for 6 h and cellular lysates were prepared for Western blot analyses with
antibodies as indicated. β-actin served as loading control. (H) Western blot analysis. Isolated term primary trophoblasts were treated
with increasing concentrations of forskolin for 8 h and cellular extracts were prepared for Western blot analyses with indicated
antibodies. β-actin served as loading control.
doi: 10.1371/journal.pone.0073337.g003
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PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e73337Figure 4.  Survivin is required for the proliferation of trophoblastic cells and depletion induces a G2/M arrest.  (A) Cell
viability assay. JAR (left panel), BeWo (middle panel) and HTR-8/SVneo (HTR, right panel) cells were non-treated (con), treated
with either control scrambled siRNA (si con) or siRNA targeting survivin (si survivin) and cell viability was analyzed at indicated time
points. Bar: ± SD. (B) Cell cycle profiles. Cells were depleted of survivin for 48 h and cell cycle analysis was performed. con:
untreated cells as control. si con: treated with control scrambled siRNA. si survivin: treated with siRNA against survivin. Right
panels: quantification of the sub-phases of the cell cycle. (C) Western blot analysis. BeWo cells were transfected with scrambled
siRNA (si con) or siRNA targeting survivin (si survivin) for 24 h or 48 h and cellular extracts were prepared for Western blot analysis
using indicated antibodies. β-actin served as loading control. con: non-treated lysates as control. (D) Relative caspase-3/7 activity.
The lysates from JAR or BeWo cells treated as in (C) were used for evaluating caspase-3/7 activity. The results are presented as
mean ± SD.
doi: 10.1371/journal.pone.0073337.g004
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PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e73337Figure 5.  Trophoblastic cells are affected by survivin suppressant YM155.  (A) Western blot analysis. JAR cells were treated
with increasing concentrations of YM155 for 24 h and cellular extracts were prepared for Western blot analysis. β-actin served as
loading control. Untreated (con) and DMSO treated cellular extracts were taken as controls. (B) Cell cycle profiles. Cells were
treated as in (A) and cell cycle analysis was performed. DMSO treated cells were taken as controls. (C) Quantification of the sub-
phases of the cell cycle. (D) Relative caspase-3/7 activity. The lysates from JAR cells treated with DMSO or 10, 20 and 30 nM
YM155 for 24 h were used for evaluating caspase-3/7 activity. The results are presented as mean ± SD. (E) Cell viability assay. JAR
cells were non-treated (con), treated with DMSO or with increasing concentrations of YM155 for 24 h and cell viability was analyzed.
Bar: ± SD.
doi: 10.1371/journal.pone.0073337.g005
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PLOS ONE | www.plosone.org 9 September 2013 | Volume 8 | Issue 9 | e73337Figure 6.  Survivin is required for chromosome alignment
and centrosome integrity in trophoblastic cells.  (A) BeWo
cells were untreated (1st panel), treated with scrambled siRNA
(si con, 2nd panel) or siRNA against survivin (si survivin, 3rd to
6th  panels)  for  36  h.  Cells  were  then  fixed  and  stained  for
tubulin, pericentrin and DNA, and analyzed by confocal laser
scanning microscopy. Scale bar: 5 µm. Arrow: indicating either
chromosome congression defect (DAPI staining) or failure of
centrosome integrity (pericentrin staining). (B) Quantification of
defects in chromosome congression in metaphase cells treated
as in (A) (n=150 metaphase cells per condition). The results
are  presented  as  mean  ±  SD  and  statistically  analyzed
between siRNA control and siRNA survivin group. **p < 0.01.
(C) Quantification of abnormal centrosomes in metaphase cells
treated as in (A) (n=150 metaphase cells per condition). The
results are presented as mean ± SD and statistically analyzed
between siRNA control and siRNA survivin group. **p < 0.01.
(D) The same experiments were also performed with JAR cells.
Quantification  of  defect  in  chromosome  congression  in  JAR
metaphase cells treated as in (A) (n=150 metaphase cells per
condition).  The  results  are  presented  as  mean  ±  SD  and
statistically  analyzed  between  siRNA  control  and  siRNA
survivin  group.  ***p  <  0.001.  (E)  Quantification  of  abnormal
centrosomes in JAR metaphase cells treated as in (A) (n=150
metaphase cells per condition). The results are presented as
mean ± SD and statistically analyzed between siRNA control
and siRNA survivin group. **p < 0.01.
doi: 10.1371/journal.pone.0073337.g006
phospho-histone H3 (Thr-3) [41,42], we were next interested in
the  localization  of  Aurora  B  in  mitotic  trophoblast  cells.  JAR
cells  were  depleted  of  survivin  (Figure  7C)  and  stained  for
tubulin, DNA and Aurora B. Metaphase cells were evaluated by
confocal laser scanning microscopy. Compared to control cells
(Figure 7A, 1st and 2nd panels), JAR cells depleted of survivin
displayed much weaker or no clear staining of Aurora B at the
centromeres/kinetochores in metaphase (Figure 7A, 3rd and 4th
panels). The localization of Aurora B was deregulated in over
60% of JAR cells in the absence of survivin (Figure 7B). The
same experiment was also carried out in BeWo cells (Figure
7D and F) and over 70% of BeWo cells deficient in survivin
demonstrated  a  defect  in  Aurora  B  localization  at  the
centromeres/kinetochores (Figure 7E).
Using ACA (anti-centromere antibody) staining, the distance
of  sister  centromeres,  a  marker  of  Aurora  B  activity  in
metaphase, was evaluated in trophoblastic cells. Compared to
BeWo cells treated with control siRNA, the distance of sister
centromeres  was  shorter  in  BeWo  cells  treated  with  siRNA
against survivin (Figure 8A and C). The experiment was also
performed  in  JAR  cells  and  similar  results  were  observed
(Figure 8B and D). The data imply that depletion of survivin
results in mis-localization and reduced activity of Aurora B in
metaphase trophoblastic cells.
Discussion
A precisely regulated proliferation, differentiation, apoptosis
and  invasion  of  trophoblasts  is  of  essential  importance  for
placental development during gestation. Deregulation of these
processes  induces  disorders  in  pregnancy,  such  as
preeclampsia.  As  a  member  of  the  CPC,  an  inhibitor  of
apoptosis, a modulator of stress and a regulator of invasion,
survivin  may  play  multiple  pivotal  roles  in  various  types  of
placental cells throughout different stages of gestation.
In this study we show that the survivin gene is reduced in
preeclamptic placentas compared to normal controls (Figure 1),
which is consistent with previous results [21]. The transcription
of survivin is controlled by specific sequences in its promoter: it
increases  during  G1  and  reaches  its  peak  in  G2/M  [43].
Numerous  factors/pathways  are  involved  in  survivin  up-
regulation,  such  as  the  nuclear  factor-κB  (NF-κB)/
phosphatidylinositol 3-kinase (PI3K)/Akt pathway [44], insulin-
like  growth  factor-1  (IGF-1)/mTOR  signaling  [3],  members  of
the Ras oncogene family [45], signal transducer and activator
of  transcription  3  (STAT3)  [46]  and  the  anti-apoptotic  factor
Wnt-2  [47].  On  the  other  hand,  survivin  is  one  of  the  genes
repressed  at  the  transcriptional  level  by  p53  [48,49].  In
preeclamptic  placentas,  NF-κB,  IGF-1  and  STAT3  are  up-
regulated  [50–52],  which  cannot  explain  the  decrease  in  the
survivin  gene.  Intriguingly,  p53  is  increased  in  preeclampsia
[20].  Whether  the  deregulated  p53  and  other  tumor
suppressors account for the reduction of the survivin gene in
preeclamptic placentas remains to be elucidated. It will be also
interesting  to  study  if  altered  epigenetic  modifications  or
deregulated  microRNAs  are  responsible  for  the  reduced
survivin gene in preeclamptic placentas.
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PLOS ONE | www.plosone.org 10 September 2013 | Volume 8 | Issue 9 | e73337Figure 7.  Localization of Aurora B at the centromeres/kinetochores is reduced after depletion of survivin.  (A) JAR cells
were untreated (1st panel), treated with scrambled siRNA (si con, 2nd panel) or siRNA against survivin (si survivin, 3rd and 4th panels)
for 36 h. Cells were then stained for tubulin, DNA and Aurora B, and analyzed by confocal laser scanning microscopy. Scale bar: 5
µm. (B) Quantification of weak/no staining of Aurora B in metaphase cells treated as in (A) (n=90 metaphase cells per condition).
The results are presented as mean ± SD and statistically analyzed between control and siRNA survivin group. **p < 0.01. (C)
Western blot analysis as siRNA efficiency control. β-actin served as loading control. (D) BeWo cells were untreated (con, 1st panel),
treated with scrambled siRNA (si con, 2nd panel) or siRNA against survivin (si survivin, 3rd and 4th panels) for 36 h. Cells were then
stained for tubulin, Aurora B and DNA, and analyzed by confocal laser scanning microscopy. Scale bar: 5 µm. (E) Quantification of
weak/no staining of Aurora B in BeWo metaphase cells treated as in (D) (n=90 metaphase cells per condition). The results are
presented as mean ± SD and statistically analyzed between control and siRNA survivin group. **p < 0.01. (F) Western blot analysis
as siRNA efficiency control. β-actin served as loading control.
doi: 10.1371/journal.pone.0073337.g007
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PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e73337Figure 8.  The distance of the sister centromeres is reduced in trophoblastic cells depleted of survivin.  (A) BeWo cells were
treated with scrambled siRNA (si con, upper panel) or siRNA against survivin (si survivin, lower panel) for 36 h. Cells were then
stained for tubulin, DNA, the centromere with anti-centromere antibody (ACA) and Aurora B. The stained metaphase cells were
analyzed by confocal laser scanning microscopy. Scale bar: 5 µm. Insets show representative sister centromeres with four fold
magnification. (B) JAR cells were treated with scrambled siRNA (si con, upper panel) or siRNA against survivin (si survivin, lower
panel) for 36 h. Cells were then stained for tubulin, DNA, the centromere with ACA and Aurora B. The stained metaphase cells were
analyzed by confocal laser scanning microscopy. Scale bar: 5 µm. Insets show representative sister centromeres with four fold
magnification. (C) Evaluation of the distance of the sister centromeres in BeWo cells. Cells were treated as in (A) and the length of
paired ACA staining was evaluated (n=52 pairs per condition) with LAS AF software. The results are presented as mean ± SD and
statistically analyzed between siRNA control and siRNA survivin group. ***p < 0.001. (D) Evaluation of the distance between sister
centromeres  in  JAR  cells.  Cells  were  treated  as  in  (B)  and  the  length  of  paired  ACA  staining  was  evaluated  (n=50  pairs  per
condition)  with  LAS  AF  software.  The  results  based  on  three  independent  experiments  are  presented  as  mean  ±  SEM  and
statistically analyzed between siRNA control and siRNA survivin group. *p < 0.05.
doi: 10.1371/journal.pone.0073337.g008
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PLOS ONE | www.plosone.org 12 September 2013 | Volume 8 | Issue 9 | e73337Unexpectedly, the protein level of survivin is not correlated to
its gene level in preeclamptic placenta (Figure 2). We could not
observe  a  clear  difference  in  the  protein  level  of  survivin
between  the  preeclampsia  group  and  the  control  group  by
applying  Western  blot  analysis  and  immunohistochemical
staining as well (Figure 2A-F). The protein level of survivin in
preeclampsia has been controversially reported, and our data
are in line with one study [20] yet in contradiction with another
[21]. As trophoblasts in preeclamptic placenta constantly meet
stress, we assumed that the discrepancy between decreased
gene  and  unchanged  protein  level  of  survivin  could  be
explained  by  protein  stabilization  upon  stress.  Indeed,  the
protein survivin is stabilized upon stress in trophoblast cell lines
as well as in primary trophoblast cells (Figure 3). It has been
reported that stabilization of survivin could result from altered
ubiquitin-proteasome pathways regulating survivin degradation
[53,54],  changed  activation  of  proteins  responsible  for  the
turnover of survivin, such as Hsp90 [55], or alternatively from
the  post-translational  modifications  of  survivin,  such  as
phosphorylation  [56].  Indeed,  increased  Hsp90  and
phosphorylated  serine  20  in  survivin  were  observed  in
trophoblastic  cells  after  H2O2  treatment  (Figure  3A  and  G).
Moreover,  phosphorylation  of  the  serine  20  is  linked  to
activated PKA in trophoblastic cells upon stress (Figure 3D and
H),  which  is  in  line  with  the  observation  that  PKA  activity  is
associated with increased cell survival [57,58]. Based on our
data,  we  suggest  that  activated  PKA  and  increased  Hsp90
could  account  for  stabilized  survivin  in  trophoblasts  in
preeclampsia  via  phosphorylation  and  the  proteasome
degradation  pathway,  respectively.  Moreover,  apoptosis
induction  is  reversely  correlated  with  the  levels  of  survivin
(Figure  3E  and  F,  Figure  4C  and  D,  Figure  5A  and  D  and
Figure  S2A)  indicating  that  survivin  is  responsible  for  the
survival  in  trophoblastic  cells  facing  stress.  It  is  plausible  to
propose  that,  in  order  to  survive  the  stress,  trophoblasts  in
preeclamptic placenta will turn on all the rescue mechanisms to
stabilize/activate cytoprotection proteins, such as survivin. It is
also conceivable to suggest that the harmful consequence will
appear if the rescue mechanisms are exhausted or not able to
work, possibly in the case of severe preeclampsia.
Survivin  is  found  in  villous  cytotrophoblasts  and
syncytiotrophoblasts (Figure 2C), supporting the previous data
[17,20,21].  However,  while  we  observe  the  survivin  signal
predominantly in the nucleus (Figure 2C), the others detected
the  staining  mostly  in  the  cytoplasm  and  only  rarely  in  the
nucleus of placental cells [20,21]. To corroborate our data from
immunohistochemical  staining,  we  performed  Western  blot
analysis  using  nuclear  and  cytosol  extracts,  which  clearly
demonstrates that the main pool of survivin in placenta cells is
localized  in  the  nucleus  (Figure  2G).  This  discrepancy  could
possibly  be  attributed  to  lower  sensitivity  and  specificity  of
survivin antibodies used previously by other groups. Survivin is
a  nuclear  cytoplasmic  shuttling  protein  [59]  and  these
subcellular pools coincide with different survivin functions [1].
Since the nuclear pool of survivin mediates survivin’s function
in  mitosis  [7,8],  we  suggest  that  survivin  accumulated  in  the
nucleus  of  cytotrophoblasts  and  of  syncytial  sprout  cells  is
properly responsible for survival and proliferation. Moreover, it
has  been  reported  that  the  nuclear  localization  of  survivin
correlates  with  its  accelerated  proteosomal  degradation  [53]
and acts as an apoptotic executor and thus commits a cell to
apoptosis  [60].  It  is  intriguing  to  ask  whether  the  survivin
nuclear  localization  observed  in  differentiated
syncytiotrophoblasts  (Figure  2C)  could  also  promote  the
turnover of survivin and facilitate the fusion process. Further
investigations are required to study the individual function of
survivin in each cell type of the placenta.
As survivin is a member of the CPC, we have investigated its
effect on mitotic progression and proliferation in trophoblasts.
Indeed, survivin is critical for the viability of three trophoblast
cell  lines  (Figure  4A,  5E  and  Figure  S2D),  regardless  of
malignancy  or  benignity.  Depletion/suppression  of  survivin
arrests trophoblastic cells in G2/M (Figure 4B, Figure 5B and
C, and Figure S2B and C), followed by apoptosis (Figure 4C
and  D,  Figure  5A  and  D,  and  Figure  S2A).  Furthermore,
suppression  of  survivin  in  trophoblastic  cells  induces  strong
defects in chromosome congression (Figure 6), in centrosome
integrity (Figure 6), in proper localization and activity of Aurora
B in metaphase (Figure 7 and Figure 8). Collectively, the data
demonstrate  that  survivin,  like  in  tumor  cells,  is  of  essential
importance for proper mitotic progression of trophoblastic cells
in the placenta.
Conclusion
Taken together, we show that the survivin gene is reduced
but  the  protein  level  of  survivin  is  hardly  changed  in
preeclampsia placentas, in comparison with control placentas.
This discrepancy between the gene level and protein amount
can be explained by stabilization of the survivin protein under
stress.  Survivin  promotes  the  survival  of  trophoblastic  cells
challenged  by  stress.  It  plays  pivotal  roles  in  mitotic
progression  in  trophoblastic  cells  of  the  placenta.  Interfering
with  survivin  induces  severe  mitotic  defects  followed  by
apoptosis.  More  investigations  are  required  to  explore  the
function of survivin in individual cell types of the placenta. It is
tempting to propose that survivin plays multifaceted roles in the
placenta  development  in  terms  of  proliferation,  cell  cycle
control, apoptosis, angiogenesis and invasion. Its alteration is
possibly involved in the pathogenesis of the placenta.
Supporting Information
Figure  S1.    Characterization  of  isolated  primary
trophoblasts  from  term  placentas.  (A)  Indirect
immunofluorescence  staining  with  antibodies  against  DNA,
cytokeratin-7 and cytokeratin-18 (upper panel) or against DNA,
vimentin and cytokeratin-18 (lower panel). Representatives are
presented. Scale bar: 20 µm. (B) Evaluation of positive stained
cells.
(TIF)
Figure  S2.    Bewo  cells  are  affected  by  survivin
suppressant  YM155.  (A)  Western  blot  analysis.  BeWo  cells
were treated with increasing concentrations of YM155 for 48 h
and cellular extracts were prepared for Western blot analysis.
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PLOS ONE | www.plosone.org 13 September 2013 | Volume 8 | Issue 9 | e73337β-actin served as loading control. Untreated (con) and DMSO
treated cellular extracts were taken as controls. (B) Cell cycle
profiles. Cells were treated as in (A) and cell cycle analysis was
performed.  DMSO  treated  cells  were  taken  as  controls.  (C)
Quantification  of  the  sub-phases  of  the  cell  cycle.  (D)  Cell
viability assay. BeWo cells were non-treated (con), treated with
DMSO or with increasing concentrations of YM155 for 48 h and
cell viability was analyzed. Bar: ± SD.
(TIF)
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